Top Life Sciences Startups to Watch in 2021 - Triumvira Immunologics | Engineered T Cell Therapies
NextGen Bio Class of 2021
BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life sciences companies in North America that recently launched. To come up with this list, BioSpace looked at companies that recently launched over the past few years with Series A funding. They were then weighted by several different categories and ranked in a cumulative fashion, based on the points awarded for each category. These categories were: finance, collaborations, pipeline, growth potential, and innovation. The NextGen Bio Class of 2021 is a stellar group of companies that are already making an enormous impact on the industry now and will continue into the future. Congratulations to this group!
Related Links
Triumvira Appoints Teresa McRoberts as Chief Financial Officer and Announces Senior Level Promotions
Bayer and Northpond Ventures Lead USD $55 Million Series A Financing Round for Triumvira Immunologics